Fruquintinib Mechanism of Action: New Frontier in Colorectal Cancer Therapy? Colorectal 13 Mins Read …The battle against cancer has led to a myriad of innovations in oncology, with each new breakthrough providing a beacon…
Phase 3 FRESCO-2 Trial Analysis of Fruquintinib mCRC Colorectal 3 Mins Read The phase 3 FRESCO-2 study evaluated the efficacy and safety of fruquintinib, a novel targeted therapy, in patients with advanced…
FRESCO-2 Trial Meets Endpoints: Metastatic Colorectal Cancer Colorectal 15 Mins Read FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
